Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826288 · ClinicalTrials.gov registry record · NA
Oncology Care at Home for BMT and CAR-T
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT05826288 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 11 participants.
The verdict
NCT05826288, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
To assess the potential for successfully using technology-assisted in-home oncology care to provide improved care coordination and management, and appropriate referral to treatment for patients receiving bone marrow transplant (BMT) or chimeric antigen receptor (CAR) T-cell therapy (CAR-T). The technology-assisted in-home oncology care program includes remote patient monitoring (RPM), telemedicine, and home-based health care services.
Interventions
- OTHER BioIntelliSense BioButton Rechargable
- OTHER Memora Health two-way patient engagement platform provided by RC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05826288
The ClinicalTrials.gov registry entry for NCT05826288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BioIntelliSense BioButton Rechargable is the first listed.
NCT05826288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05826288 about?
NCT05826288 is a clinical study titled "Oncology Care at Home for BMT and CAR-T". To assess the potential for successfully using technology-assisted in-home oncology care to provide improved care coordination and management, and appropriate referral to treatment for patients receiving bone marrow transplant (BMT) or chimeric antigen receptor (CAR) T-cell therapy (CAR-T). The tech...
What is the current status of trial NCT05826288?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2023-03-29. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05826288?
The interventions under investigation include: BioIntelliSense BioButton Rechargable (OTHER), Memora Health two-way patient engagement platform provided by RC (OTHER).
Who is sponsoring clinical trial NCT05826288?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.